Allergic Rhinitis: From Pathology to Novel Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 547
Special Issue Editor
2. Department of Allergy, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China
Interests: allergic rhinitis; allergy; immunotherapy; immune mechanisms in allergy; rhinitis biomarkers
Special Issue Information
Dear Colleagues,
We are pleased to announce a new Special Issue in Biomedicines, titled “Allergic Rhinitis: From Pathology to Novel Therapeutic Approaches”, and invite you to submit your original research or review articles to this collection.
This Special Issue aims to bridge mechanistic insights into allergic rhinitis (AR) with cutting-edge therapeutic strategies. We welcome submissions exploring topics including (but not limited to) the following: immune dysregulation and molecular pathways, driving AR pathology; biomarker discovery for diagnosis, prognosis, or treatment response prediction; novel immunotherapies; microbiome–host interactions in AR development and progression; and precision medicine approaches integrating omics technologies or AI-driven models.
Accepted papers after peer review will be published in this Open Access issue, ensuring global visibility and impact. Please let us know if you are interested in submitting work to this Special Issue.
Prof. Dr. Shaoqing Yu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- allergic rhinitis
- immunotherapy
- immune mechanisms in allergy
- rhinitis biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
